Read the latest news from INA and all of the official press releases.

Indonesia Investment Authority (INA) has strengthened its healthcare collaboration with China by partnering with GL Capital, a leading healthcare-focused private equity firm. CEO of INA Ridha Wirakusumah emphasized healthcare as a strategic priority, with investments in pharmaceuticals, hospitals, clinics, and diagnostics. Speaking at the "Southeast Asia - China Healthcare Summit" in Jakarta, Wirakusumah expressed optimism that discussions with GL Capital and top Chinese firms would foster collaborations to enhance healthcare innovation and access in Indonesia. The summit connected over 20 CEOs from Chinese firms with 15 Indonesian companies to explore investment opportunities, with GL Capital committed to advancing Indonesia's healthcare sector.

At the ASFA Investment Summit, the CEO of INA, Dr. Ridha Wirakusumah, encouraged institutional investors to consider Southeast Asia’s emerging markets, highlighting that strategic partnerships with local investment partners can help mitigate risks and unlock opportunities. Ridha Wirakusumah emphasized a gradual approach, advising investors to tackle these markets “one transaction at a time,” as INA has done through collaborations with global institutions like Canada’s Ontario Teachers’ Pension Plan and Singapore’s GIC. While Indonesia has made strides, Ridha Wirakusumah acknowledged that corruption remains a concern but can be managed through strong partnerships and due diligence. Other panelists echoed his views, stressing that foreign investors must build trusted relationships and take time to understand these dynamic markets, which offer significant long-term potential, given Southeast Asia's growing population and evolving regulatory landscape.

The Indonesia Investment Authority (INA) and Hong Kong-based Swire Pacific Limited have finalized an investment in the Indonesian state-owned hospital chain PT Pertamina Bina Medika IHC (IHC) on Wednesday (14/08). This collaboration, initiated in December 2023, aims to improve Indonesia's healthcare system through organizational transformation, digitalization, and human resource development. The partnership also includes the development of new hospitals, such as Bali International Hospital and Panorama Balikpapan Hospital, further expanding IHC's network of 37 hospitals and 66 clinics nationwide. INA plays a crucial role by leveraging its local expertise to collaborate with IHC and Swire Pacific, improving access to quality healthcare services in Indonesia. This aligns with INA's mission to attract foreign investment and support national strategic projects, with the healthcare sector as a key development pillar.

During media visit to the editorial board of Bisnis Indonesia on Tuesday (13/8) CEO of The Indonesia Investment Authority (INA)Ridha Wirahadikusuma said on that the company has significantly expanded its assets under management (AUM), reaching IDR 160 trillion in 2024, marking substantial growth since its establishment in 2020. INA received an initial capital injection of IDR 75 trillion, consisting of IDR 30 trillion in cash and IDR 45 trillion in shares. Through optimal performance, INA successfully increased its managed funds without requiring additional capital injections. Ridha also mentioned that INA has obtained a good credit rating from Fitch Ratings, with a BBB rating for international credit and AAA(idn) for national credit. INA continues to attract global investors by promoting long-term projects aligned with ESG principles, making it a key player in driving sustainable economic development in Indonesia.

Indonesia Investment Authority (INA) reported a net profit of IDR 4.3 trillion for the year 2023, marking a 64% increase compared to the previous year. CEO of INA Ridha Wirakusumah said "This financial performance achievement is inseparable from the performance of INA's investment portfolio and the optimization of INA's asset management, carried out prudently and with discipline in overall cost management," during his visit to IDN HQ on Wednesday (7/8). This growth was driven by interest income from investments and treasury assets, dividends, and unrealized gains. INA's cumulative investments since its establishment reached IDR 50.1 trillion, with INA's portion amounting to IDR 31.3 trillion. Total Assets Under Management (AUM) for INA grew by 34.3% year-on-year to IDR 147.6 trillion, with key sectors including healthcare, green energy, toll roads, logistics, and digital infrastructure. Despite global economic uncertainties, INA's robust performance highlights its role in strengthening Indonesia's economic resilience through strategic investments and sound financial management.

PT Hutama Karya (HK) has built approximately 1,030 km of toll roads in Indonesia over the past decade, supported by State Capital Injections (PMN) amounting to IDR 131.14 trillion since 2015. Despite receiving substantial PMN, HK's financial burden increased, with debt soaring by 958.46% since 2014, reaching IDR 53.11 trillion in 2023. Throughout 2023, PT Hutama Karya (HK) managed to reduce its debt to IDR 53.11 trillion, down 24.70% from the previous year, thanks to investment collaboration with the Indonesia Investment Authority (INA) and State Capital Injection (PMN) support for National Strategic Projects. In the first half of 2024, HK recorded a net profit of IDR 396 billion, a significant increase from IDR 34 billion in the same period last year, with total assets rising 2,732% since 2014. The company continues to grow positively due to the construction of the Trans Sumatra Toll Road and being selective in choosing quality projects.